( Ground-breaking results from researcher...)Targeted drug delivery achieved with nanoparticle-aptamer bioconjugates

Ground-breaking results from researchers at Harvard Medical School and Massachusetts Institute of Technology (MIT), USA, disclosed at the 13th European Cancer Conference (ECCO) have shown for the first time that targeted drug delivery is possible using nanoparticle-apatamer conjugates.

Nucleic acid ligands (referred to as aptamers) are short DNA or RNA fragments that can bind to target antigens with high specificity and affinity; analogous to monoclonal antibodies. In the field of cancer nanotechnology, aptamers have the potential to act as targeting molecules - directing the delivery of nanoparticles to tumour-antigens, present on the surface of cancer cells. In general terms, therapeutic nanoparticles (~50 ?~250 nanometer) are specially designed delivery vehicles that can encapsulate a drug within them and release the drug in a pre-determined and regulated manner which can vary from a sudden release to a slow release over a period of several years. Using prostate cancer as a model disease, proof of concept nanoscale targeted drug delivery vehicles were developed (1 nanometer = 0.000000001 meter), which can target prostate cancer cells with high specificity and efficiency. Once bound to prostate cancer cells, the nanoparticle/aptamer bioconjugates were internalised making it possible for their cytotoxic payload to get released directly inside the cancer cells. The combination of targeted delivery and controlled release of drugs at the site of cancer will likely result in "smart therapeutics" that are more effective, yet safer than what is available today.

As the initial step, researchers synthesised nanoparticles for controlled drug release made from a biocompatible and biodegradable PLA polymer system and encapsulated a fluorescently labeled model drug within them, in order to visualise nanoparticle uptake into target cells. The nanoparticles in question were designed for attachment to aptamers so that the binding properties of aptamers for targeti
'"/>

Source:Federation of European Cancer Societies

Page: 1 2 3 4
Related biology news :

1. Affymetrix and ParAllele Launch Industrys Most Comprehensive Product Line for Targeted Genotyping
2. Targeted virus compels cancer cells to eat themselves
3. New methods of gene delivery using lasers
4. Recombinant DNA technology may enable oral, rather than injectable, delivery of protein drugs
5. Self-assembled DNA buckyballs for drug delivery
6. Cookbook recipes would cure disease with nontoxic DNA delivery systems
7. Cellular scale drug delivery from the inside out
8. Wrinkled membranes create novel drug-delivery system
9. Scientists force viruses to evolve as better delivery vehicles for gene therapy
10. New self-exploding microcapsules could take sting out of drug delivery
11. Coated nanoparticles solve sticky drug-delivery problem